Advertisement

Lung Transplantation in Infants and Children - Indications, Surgical Techniques, and Special Considerations

  • J. E. Davis
  • V. A. Starnes

Abstract

Lung transplantation (LTx) in infants and children has its roots in the adult LTx experience. The first LTx was performed by Hardy (Chapter 18, Figure 9) et al. [1] in 1963 on a patient with squamous cell carcinoma of the lung (Chapter 45). The patient lived for 17 days and died of renal failure. The autopsy results showed intact anastomoses. For the next 17 years there were numerous failures by those who attempted to repeat Hardy’s feat until 1981, when Reitz (Chapter 66, Figure 5) et al.[1] accomplished the first heart-lung transplant. Then in 1983, Joel Cooper (Chapter 45, Figure 1) et al.[1] performed a successful single lung transplant. These advances were mainly due to the introduction of cyclosporin and improved bronchial anastomotic techniques, namely bronchial wrapping with an omental pedicle. These events mark the beginnings of pulmonary transplantation, and the lessons learned were applied to the pediatric heart-lung and lung transplant population in the late 1980s[4],[5].

Keywords

Pulmonary Artery Pulmonary Hypertension Pulmonary Vein Patent Ductus Arteriosus Hypoplastic Left Heart Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hardy JD, Webb WR, Dalton ML, Walker GR. Lung homotransplantation in man. J Am Med Assoc.1963;186:1965.Google Scholar
  2. 2.
    Reilz BA, Wallwork, J. Hunt SA et al. Heart-lung transplantation. Successful therapy for patients with pulmonary vessel disease. N Engl J Med. 1982;306:557.CrossRefGoogle Scholar
  3. 3.
    Cooper JD, Pearson FG, Patterson GA et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg. 1987;93:173.PubMedGoogle Scholar
  4. 4.
    Starnes VA, Over PE, Bernstein D et al. Heart, heart-lung, and lung transplantation in the first year of life. Ann Thorac Surg. 1992;53:306.PubMedCrossRefGoogle Scholar
  5. 5.
    Starnes VA, Marshall SE, Lewiston NJ et al. Heart-lung transplantation in infants, children and adolescents. J Ped Surg. 1991;26:434.CrossRefGoogle Scholar
  6. 6.
    Starnes VA, Lewiston N, Theodore J et al. Cystic fibrosis: target population for lung transplantation in North America in the 1990s. J Thorac Cardiovasc Surg. 1992;103:1008.PubMedGoogle Scholar
  7. 7.
    Wagenvoort CA, Wagenvoort N. Primary pulmonary hypertension: a pathologic study of the lung vessels in 56 clinically diagnosed cases. Circulation. 1970;42:1163.Google Scholar
  8. 8.
    Rich S, Levy PS. Characteristics of surviving and non-surviving patients with primary pulmonary hypertension. Am J Med. 1984;76:573.PubMedCrossRefGoogle Scholar
  9. 9.
    D’Alonzo GE, Barst RJ, Avers SM et al. Survival in patients with primary pulmonary hypertension. Results from a nation prospective registry. Ann Intern Med. 1991;115:343.PubMedGoogle Scholar
  10. 10.
    Eysmann SB, Palevsky HI, Reichek N, Hackney K, Douglas PS. Two dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation. 1989;80:353.PubMedGoogle Scholar
  11. 11.
    Glanville AR, Burke CM, Theodore J, Robin ED. Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation. Chest. 1987;91:675.PubMedGoogle Scholar
  12. 12.
    Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation. Eleventh official report. 1994. J Heart Lung Transplant. 1994:13:561.PubMedGoogle Scholar
  13. 13.
    Lupinetti FM, Boiling FS, Bove EL et al. Selective lung or heart-lung transplantation for pulmonary hypertension associated with congenital cardiac anomalies. Ann Thorac Surg. 1994;57:1545.PubMedCrossRefGoogle Scholar
  14. 14.
    Bridges ND, Mallory GB, Huddleston CB et al. Lung transplantation in children and young adults with cardiovascular disease. Ann Thorac Surg. 1995;59:813.PubMedCrossRefGoogle Scholar
  15. 17.
    Myers BD, Ross J, Newton I. et al. Cydosporine-associaled chronic nephropalhy. N Engl J Med. 1984;311:699.PubMedCrossRefGoogle Scholar
  16. 18.
    Marshall SE, Mordechai RK, Lewiston NJ et al. Selection and evaluation of recipients for heart-lung and lung transplantation. Chest. 1990;96:1488.Google Scholar
  17. 19.
    Calhoon JH, Gover EL, Gibbons WJ et al. Single lung transplantation: alternative indications and techniques. J Thorac Cardiovasc Surg. 1991;101:816.PubMedGoogle Scholar
  18. 20.
    Patterson GA, Cooper JD et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg. 1988;45:626.Google Scholar
  19. 21.
    Pasque MK, Cooper JD, Kaiser LR et al. Improved technique for bilateral lung transplantation: rational and initial clinical experience. Ann Thorac Surg. 1990;49:785.PubMedCrossRefGoogle Scholar
  20. 22.
    Bisson A, Bonnette P.A new technique for double lung transplantation: ‘bilateral single lung’ transplantation. J Thorac Cardiovasc Surg. 1992;103:40PubMedGoogle Scholar
  21. 23.
    Spray TL, Mallory GB, Canter CB, Huddleston CB. Pediatric lung transplantation: indications, technique and early results. J Thorac Cardiovasc Surg. 1994;107:990.PubMedGoogle Scholar
  22. 24.
    Bolman RM. Pediatric lung and heart-lung transplantation. Transplant Proc. 1994;26:211.PubMedGoogle Scholar
  23. 25.
    Spray TL, Huddleston CB. Pediatric lung transplantation. Chest Surg Clin N Am. 1993;3:123.Google Scholar
  24. 26.
    Lima O, Cooper JD, Peters WJ. Effects of melhylprednisolone and azathioprine on bronchial healing following lung autotransplantation. J Thorac Cardiovasc Surg. 1981;82:211.PubMedGoogle Scholar
  25. 27.
    Starnes VA. Risks of childhood immunosuppression. J Heart Lung Transplant. 1991;10:832.Google Scholar
  26. 28.
    Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK506 and rapamycin. J Immunol. 1990;144:251.PubMedGoogle Scholar
  27. 29.
    McCaulcy J. The nephrotoxicity of FK506 as compared with cyclosporin. Curr Opinion Nephr Hypertension. 1993;2:662.CrossRefGoogle Scholar
  28. 30.
    Armitage JM, Fricker FJ, Nel Nido P, Cipriani L. Starzl TE. The clinical trial of FK506 as primary and rescue immunosuppression in pediatric cardiac transplantation. Transplant Proc. 1991;23:3058.PubMedGoogle Scholar
  29. 31.
    Armitage JM, Fricker JE, Kurland G et al. Pediatric lung transplantation: the years 1985 to 1992 and the clinical trial of FK506. J Thorac Cardiovasc Surg. 1993;105:337.PubMedGoogle Scholar
  30. 32.
    Bando K, Paradis IL, Similo S et al. Obliterative bronchinlitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg. 1995;110:4PubMedCrossRefGoogle Scholar
  31. 33.
    Randhawa PS, Yousem S, Paradis IL et al. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferativc disorders in heart-lung transplant recipients. Am J Clin Pathol. 1989;92:177.PubMedGoogle Scholar
  32. 34.
    Nalcsnik MA, Jaffe R. Starzl TF et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol. 1988;133:173.Google Scholar
  33. 35.
    Armitage JM, Kormos RL, Stuart RS et al. Posttransplantation lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporin-based immunosuppression. J Heart Lung Transplant. 1991; 10:877.PubMedGoogle Scholar
  34. 36.
    Armitage JM, Kurland G, Michaels M et al. Critical issues in pediatric lung transplantation. J Thorac Cardiovasc Surg. 1995;109:60.PubMedCrossRefGoogle Scholar
  35. 37.
    Bolman RM, Shumway SJ, Estrin JA, Hertz MI. Lung and heart transplantation: evolution and new applications. Ann Surg. 1991;214:456.PubMedCrossRefGoogle Scholar
  36. 38.
    Kramer MR, Valantine HA Marshall SE, Starnes VA, Theodore J, Recovery of the right ventricle alter single-lung transplantation in pulmonary hypertension. Am J Curdiol. 1994;73:494.CrossRefGoogle Scholar
  37. 39.
    Patterson GA, Todd TR, Cooper JD et al. Airway complications following doublelung transplantation. J Thorac Cardiovasc Surg. 1990;99:14.PubMedGoogle Scholar
  38. 40.
    Fremes SE, Patterson GA. Williams WG et al. Single lung transplantation and closure of patent ductus arteriosus tor Eisenmenger’s syndrome. J Thorac Cardiovasc Surg. 1990;100:1.PubMedGoogle Scholar
  39. 41.
    Bando K, Armitage JM, Paradis IL et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg. 1994;108:1056.PubMedGoogle Scholar
  40. 42.
    Nootens M, Freels S, Kaufman E, Levy PS, Rich S. Timing of single lung transplantation for primary pulmonary hypertension. J Heart Lung Transplant. 1994;13:276.PubMedGoogle Scholar
  41. 43.
    Sharples L, Belcher C, Dennis C, Higenboltam T, Wallwork J. Who waits longest for heart and lung transplantation? J Heart Lung Transplant. 1994;13:282.PubMedGoogle Scholar
  42. 44.
    Geist LJ, Monick MM, Stinski MF, Hunninghake GW, Cytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporin A on interleukin-2 gene expression. J Clin Invest. 1993;90:2136.CrossRefGoogle Scholar
  43. 45.
    Griffith, BP, Bando K, Hardesly RI. et al. Prospective randomized trial of FK506 versus cyclosporin alter human pulmonary transplantation. Transplantation. 1994;57:848.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • J. E. Davis
  • V. A. Starnes

There are no affiliations available

Personalised recommendations